期刊文献+

血清基质金属蛋白酶3在类风湿关节炎中的临床研究 被引量:11

Clinical value of matrix metalloproteinases-3 in rheumatoid arthritis
原文传递
导出
摘要 目的探讨血清基质金属蛋白酶3(MMP-3)与类风湿关节炎(RA)的相关性和临床价值。方法采用回顾性研究,收集2019年1月至2020年1月来北京市石景山医院就诊的RA病例123例,其中男25例,女98例,中位数年龄60岁;同期来院健康体检者53名,其中男12名,女41名,中位数年龄55岁。检测所有受试者的空腹外周血的MMP-3、红细胞沉降率(ESR)、超敏C反应蛋白(hs-CRP)、类风湿因子(RF)、抗环瓜氨酸肽抗体(ACCP)水平,记录28关节疾病活动度评分(DAS28)。采用t检验、Spearman相关分析及ROC曲线等统计方法,分析两组结果差异、相关性分析及血清MMP-3对RA的诊断效能。结果 RA组血清MMP-3水平为(79.71±123.54)ng/ml,明显高于对照组的(26.30±14.83)ng/ml,差异有统计学意义(t=-4.95,P<0.001)。RA组患者血清MMP-3与ESR、hs-CRP、DAS28均具有显著正相关(r值分别为0.521,0.372,0.405,P值均<0.001)。血清MMP-3诊断RA的曲线下面积(area under the curve,AUC)为0.765,取诊断界限值为32.5 ng/ml时,敏感度为64.44%,特异度为75.76%。结论 RA患者血清MMP-3水平显著升高,与RA疾病活动度高度相关,可能对RA的早期诊断、治疗监测及疾病预警有重要的作用。 Objective To analyze the relationship and clinical value between serum matrix metalloproteinases-3(MMP-3)and rheumatoid arthritis(RA).Methods By using retrospective study to collect 123 patients with RA diagnosed in our hospital from January 2019 to January 2020 as the RA group.Among the patients,there are 25 males and 98 females,the median age is 60 years old.During the same term,53 healthy people were selected as the control group,with 12 males and 41 females,the median age is 55 years old.MMP-3,erythrocyte sedimentation rate(ESR),high sensitivity C-reactive protein(hs-CRP),rheumatoid facotrs(RF),anti-cyclocitrulline factor(ACCP)in peripheral blood of all subjects were detected.Disease activity score of 28 joints(DAS28)were collected.This research used T test,Spearman correlation analysis and receiver operating characteristic curve(ROC curve)to analyze the relationship between MMP-3 and other clinical biochemical indices,and the efficacy of MMP-3 in the diagnosis of RA.Results Compared with the control group(26.30±14.83)ng/ml,the levels of serum MMP-3 in the RA group(79.71±123.54)ng/ml had significantly increased(t=-4.95,P<0.001).The serum concentration of MMP-3 in RA patients was significantly correlated with ESR,hs-CRP and DAS28(r value were 0.521,0.372,0.405 respectively,P<0.001).The area under the curve(AUC)of MMP-3 to diagnose RA was 0.765,and the sensitivity was 64.44%,and the specificity was 75.76%,cut-off of MMP-3 were 32.50 ng/ml.Conclusions The levels of serum MMP-3 in the RA group had significantly increased.MMP-3 and the disease activity were highly correlated.MMP-3 can be used as an indicator of RA disease activity,also can significantly improve the diagnostic efficacy,treatment and warning of early RA.
作者 孙艳艳 刘丽 李晔 王静 马凤云 李旭艳 董红宇 Sun Yanyan;Liu Li;Li Ye;Wang Jing;Ma Fengyun;Li Xuyan;Dong Hongyu(Department of Laboratory Medicine,Shijingshan Teaching Hospital of Capital Medical University,Beijing Shijingshan Hospital,Beijing 100043,China;Department of Rheumatology and Immunology,Shijingshan Teaching Hospital of Capital Medical University,Beijing Shijingshan Hospital,Beijing 100043,China)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2020年第6期666-669,共4页 Chinese Journal of Laboratory Medicine
关键词 类风湿关节炎 基质金属蛋白酶3 疾病活动度评分 Rheumatoid arthritis Matrix metalloproteinase-3 Disease activity score
  • 相关文献

参考文献1

二级参考文献16

  • 1Klimiuk PA,Sierakowski S,Latosiewicz R,et al.Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histologieal variants of rheumatoid synovitis. Rheumatology (Oxford),2002,41:78-87.
  • 2Yamanaka H,Matsuda Y,Tanaka M,et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement,in patients with early rheumatoid arthritis. Arthritis Rheum,2000,43:852-858.
  • 3Cunnane G,Fitz-Gerald O,Beeton C,et al. Early joint erosions and serum levels of matrix metalloproteinases 1,matrix metalloproteinases 3,and tissue inhibitor of metalloproteinases 1 in rheumatoid athritis.Arthritis Rheum,2001,44:2263 -2274.
  • 4Ishiguro N,Ito T,Obata K,et al. Determination of stromelysin-1,72 Kda type Ⅳ collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1),and TIMP-2 in synovial fluid and serum from patients with rheumatoidarthritis .J Rheumatol, 1996,23:1599-1604.
  • 5Wolfe F,Sharp JT.Radiographic outcome of recent-onset rheumatoid arthritis:a 19-year study of radiographic progression.Arthritis Rheum,1998,41:1571-1582.
  • 6Green MJ,Gough AK,Devlin J,et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology,2003,42:83-88.
  • 7Posthumus,MD,Limburg PC,Westra J. Serum matrix metalloproteinase 3in early rheumatoid arthritis is correlated with disease activity and radiological progression. J Rheumatol,2000,27:2761-2768.
  • 8Ribbens C,Andre B,Jaspar J.Matrix mettalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.J Rheumatol,2000,27:888-893.
  • 9Zucker S,Hymovitz M,Conner C,et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tis-sues:clinical experimental applications.Ann NY Acad Sci, 1999,878:212-227.
  • 10Okada Y.Proteinases and matrix degradation. In:Kelley WN,Ruddy S,Harris ED,eds.Textbook of rheumatology.6th ed. Philadelphia:WB Saunders,2000.55-72.

共引文献30

同被引文献99

引证文献11

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部